Literature DB >> 26708505

Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner.

Shangyou Zheng1, Huimou Chen2, Yingxue Wang1, Wenchao Gao1, Zhiqiang Fu1, Quanbo Zhou1, Yanhui Jiang2, Qing Lin1, Langping Tan1, Huilin Ye1, Xiaohui Zhao2, Yuming Luo1, Guolin Li1, Liangtao Ye1, Yimin Liu2, Wenzhu Li2, Zhihua Li3, Rufu Chen4.   

Abstract

Long non-coding RNAs (lncRNAs) are important regulators in pathological processes, yet their potential roles in pancreatic ductal adenocarcinoma (PDAC) are poorly understood. Here, we found that a novel lncRNA, LOC389641, was upregulated in PDAC tissues and cell lines. The expression of LOC389641 was significantly correlated with staging, lymph node metastasis and overall survival. Knockdown of LOC389641 impaired cell proliferation and invasion and induced cell apoptosis in vitro, whereas overexpression of LOC389641 had the opposite effect. The growth promoting effect of LOC389641 was also demonstrated in vivo. Further, a significant negative correlation was observed between E-cadherin levels and LOC389641 levels in vivo. Knockdown of LOC389641 upregulated E-cadherin expression, but knockdown of E-cadherin had a limited influence on LOC389641. Importantly, after E-cadherin was inhibited, the enhancement of LOC389641 on cell invasion was hindered. Moreover, the expression of LOC389641 was closely associated with its genomic neighboring gene TNFRSF10A. Lastly, knockdown experiments showed that TNFRSF10A might be a connection between LOC389641and E-cadherin. We conclude that LOC389641 promotes PDAC progression and increases cell invasion by regulating E-cadherin with the possible involvement of TNFRSF10A.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  E-cadherin; Invasion; LncRNAs; Pancreatic ductal adenocarcinoma; TNFRSF10A

Mesh:

Substances:

Year:  2015        PMID: 26708505     DOI: 10.1016/j.canlet.2015.12.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   9.756


  28 in total

Review 1.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

Review 2.  ZEB1-AS1: A crucial cancer-related long non-coding RNA.

Authors:  Jinglin Li; Zhenglong Li; Kaiming Leng; Yi Xu; Daolin Ji; Lining Huang; Yunfu Cui; Xingming Jiang
Journal:  Cell Prolif       Date:  2017-12-10       Impact factor: 6.831

Review 3.  LncRNA-ATB: An indispensable cancer-related long noncoding RNA.

Authors:  Jinglin Li; Zhenglong Li; Wangyang Zheng; Xinheng Li; Zhidong Wang; Yunfu Cui; Xingming Jiang
Journal:  Cell Prolif       Date:  2017-09-08       Impact factor: 6.831

Review 4.  The involvement of lncRNAs in the development and progression of pancreatic cancer.

Authors:  Li Duguang; He Jin; Qian Xiaowei; Xu Peng; Wang Xiaodong; Li Zhennan; Qian Jianjun; Yao Jie
Journal:  Cancer Biol Ther       Date:  2017-11-27       Impact factor: 4.742

5.  LincRNA-EPS alleviates severe acute pancreatitis by suppressing HMGB1-triggered inflammation in pancreatic macrophages.

Authors:  Shengchuan Chen; Jingfei Zhu; Li-Qiong Sun; Siying Liu; Tan Zhang; Yuepeng Jin; Chaohao Huang; Dapei Li; Haiping Yao; Jian Huang; Yanghua Qin; Mengtao Zhou; Gang Chen; Qiyu Zhang; Feng Ma
Journal:  Immunology       Date:  2021-03-07       Impact factor: 7.215

6.  A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.

Authors:  Chunxiang Ye; Zhanlong Shen; Bo Wang; Yansen Li; Tao Li; Yang Yang; Kewei Jiang; Yingjiang Ye; Shan Wang
Journal:  J Exp Clin Cancer Res       Date:  2016-12-03

7.  LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1.

Authors:  Yan-Wei Hu; Chun-Min Kang; Jing-Jing Zhao; Ying Nie; Lei Zheng; Hai-Xia Li; Xin Li; Qian Wang; Yu-Rong Qiu
Journal:  J Cell Mol Med       Date:  2017-09-18       Impact factor: 5.310

8.  Meta-analysis of the clinical value of abnormally expressed long non-coding RNAs for pancreatic cancer.

Authors:  Liangliang Lei; Jianguang Wang; Like Zhang; Yanbin Chen; Pengfei Yuan; Dechun Liu
Journal:  Oncotarget       Date:  2017-09-11

9.  Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.

Authors:  Hao Hu; Yandong Wang; Xiangya Ding; Yuan He; Zipeng Lu; Pengfei Wu; Lei Tian; Hao Yuan; Dongfang Liu; Guodong Shi; Tianfang Xia; Jie Yin; Baobao Cai; Yi Miao; Kuirong Jiang
Journal:  Mol Cancer       Date:  2018-01-31       Impact factor: 27.401

Review 10.  Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.

Authors:  Yiyin Zhang; Chao Yang; He Cheng; Zhiyao Fan; Qiuyi Huang; Yu Lu; Kun Fan; Guopei Luo; Kaizhou Jin; Zhengshi Wang; Chen Liu; Xianjun Yu
Journal:  J Hematol Oncol       Date:  2018-01-31       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.